Abstract:Highlight • The effective integration of machine learning and genetic algorithms to optimize peptide modifications offers a promising avenue for peptide design. • It introduces novel techniques for the directly modification of small peptides, particularly in cases where insufficient data is available for traditional approaches. • It strategically positions the introduction of positive charge amino acids via our model instead of a mere cumulative addition of positive charged amino-acids. • Minimal modifications to the peptide structure can exert a profound influence on the inhibitory activity of LPS-binding peptides. Introduction Antimicrobial peptides (AMPs) are valuable alternatives to traditional antibiotics, possess a variety of potent biological activities and exhibit immunomodulatory effects that alleviate difficult-to-treat infections. Clarifying the structure-activity relationships of AMPs can direct the synthesis of desirable peptide therapeutics. Objectives In this study, the lipopolysaccharide-binding domain (LBD) was identified through machine learning-guided directed evolution, which acts as a functional domain of the anti-lipopolysaccharide factor family of AMPs identified from Marsupenaeus japonicus . Methods LBD A-D was identified as an output of this algorithm, in which the original LBD Mj sequence was the input, and the three-dimensional solution structure of LBD B was determined using nuclear magnetic resonance. Furthermore, our study involved a comprehensive series of experiments, including morphological studies and in vitro and in vivo antibacterial tests. Results The NMR solution structure showed that LBD B possesses a circular extended structure with a disulfide crosslink at the terminus and two 3 10 -helices and exhibits a broad antimicrobial spectrum. In addition, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that LBD B induced the formation of a cluster of bacteria wrapped in a flexible coating that ruptured and consequently killed the bacteria. Finally, coinjection of LBD B , Vibrio alginolyticus and Staphylococcus aureus in vivo improved the survival of M. japonicus , demonstrating the promising therapeutic role of LBD B for treating infectious disease. Conclusions The findings of this study pave the way for the rational drug design of activity-enhanced peptide antibiotics. Graphical abstract Download : Download high-res image (110KB) Download : Download full-size image Employing machine learning and genetic algorithms, we developed structurally enhanced antimicrobial peptides boasting exceptional efficacy.

Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences

Discovery of Antimicrobial Peptides Targeting Acinetobacter Baumannii Via a Pre-Trained and Fine-Tuned Few-Shot Learning-Based Pipeline

Identification of antimicrobial peptides from the human gut microbiome using deep learning

Protein Language Models and Machine Learning Facilitate the Identification of Antimicrobial Peptides

Ensemble Machine Learning and Predicted Properties Promote Antimicrobial Peptide Identification

Machine Learning-Driven Discovery and Evaluation of Antimicrobial Peptides from Crassostrea gigas Mucus Proteome

Comprehensive assessment of machine learning-based methods for predicting antimicrobial peptides

An Efficient Evaluation System Accelerates α-Helical Antimicrobial Peptide Discovery and Its Application to Global Human Genome Mining

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

Discovery of AMPs from random peptides via deep learning-based model and biological activity validation

A novel bioinformatic method for the identification of antimicrobial peptides in metagenomes

Recent Progress in the Discovery and Design of Antimicrobial Peptides Using Traditional Machine Learning and Deep Learning

Machine learning for antimicrobial peptide identification and design

In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method

Antimicrobial peptides designed by computational analysis of proteomes

Deep mutational scanning and machine learning for the analysis of antimicrobial-peptide features driving membrane selectivity

Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides

Machine Learning Accelerates De Novo Design of Antimicrobial Peptides

Predicting antibacterial activity, efficacy, and hemotoxicity of peptides using an explainable machine learning framework

Discovery of antimicrobial peptides in the global microbiome with machine learning

High Throughput Meta-analysis of Antimicrobial Peptides for Characterizing Class Specific Therapeutic Candidates: An Approach